Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperosmolar Hyperglycemic State01:21

Hyperosmolar Hyperglycemic State

Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validating a blood donation awareness tool created using general practitioner and patient acceptability and preferences.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2022
Same author

Probing the light hole/heavy hole switching with correlated magneto-optical spectroscopy and chemical analysis on a single quantum dot.

Nanotechnology·2019
Same author

Monolithic Axial and Radial Metal-Semiconductor Nanowire Heterostructures.

Nano letters·2018
Same author

When ethics collides with a legal gap in emergency life-threatening conditions.

British journal of anaesthesia·2018
Same author

Recurrent Obstructive Fibrinous Tracheal Pseudomembranes in a Young English Bulldog.

Journal of veterinary internal medicine·2017
Same author

Uniform phosphorus doping of untapered germanium nanowires.

Nanotechnology·2016
Same journal

Annales francaises d'anesthesie et de reanimation·2020
Same journal

[Multimodal approach to enhance filter lifespan: are all actions equal?].

Annales francaises d'anesthesie et de reanimation·2014
Same journal

[Disparity of French Emergency medical services equipment: disparity of funding allocation or of management quality?].

Annales francaises d'anesthesie et de reanimation·2014
Same journal

[Eligibility to a Maastricht III - type organ donation according to the protocol proposed by the French organ procurement organization (Agence de la biomedicine) among patients in a medico surgical intensive care unit].

Annales francaises d'anesthesie et de reanimation·2014
Same journal

[Enhanced recovery after elective colorectal surgery: reply].

Annales francaises d'anesthesie et de reanimation·2014
Same journal

[Aorto-right atrial fistula as complication of aortic dissection].

Annales francaises d'anesthesie et de reanimation·2014
See all related articles

Related Experiment Video

Updated: Jun 11, 2026

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models
10:49

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models

Published on: June 16, 2022

[Hydroxyethyl starch].

F Wierre1, E Robin, O Barreau

  • 1Pôle d'anesthésie-réanimation, hôpital Huriez, CHRU de Lille, rue Polonovski, 59037 Lille cedex, France.

Annales Francaises D'Anesthesie Et De Reanimation
|July 13, 2010
PubMed
Summary
This summary is machine-generated.

Recent hydroxyethyl starch (HES) formulations aim to minimize side effects like renal dysfunction and hemostasis issues. Newer HES solutions focus on reduced molecular weight and modified substitution rates for safer plasma volume expansion.

More Related Videos

The Synthesis of RGD-functionalized Hydrogels as a Tool for Therapeutic Applications
09:30

The Synthesis of RGD-functionalized Hydrogels as a Tool for Therapeutic Applications

Published on: October 7, 2016

Bioprinting Cellularized Constructs Using a Tissue-specific Hydrogel Bioink
08:34

Bioprinting Cellularized Constructs Using a Tissue-specific Hydrogel Bioink

Published on: April 21, 2016

Related Experiment Videos

Last Updated: Jun 11, 2026

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models
10:49

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models

Published on: June 16, 2022

The Synthesis of RGD-functionalized Hydrogels as a Tool for Therapeutic Applications
09:30

The Synthesis of RGD-functionalized Hydrogels as a Tool for Therapeutic Applications

Published on: October 7, 2016

Bioprinting Cellularized Constructs Using a Tissue-specific Hydrogel Bioink
08:34

Bioprinting Cellularized Constructs Using a Tissue-specific Hydrogel Bioink

Published on: April 21, 2016

Area of Science:

  • Pharmacology and Biophysics
  • Clinical Medicine

Context:

  • Hydroxyethyl starch (HES) has been used for plasma substitution since 1970.
  • Recent advancements in HES aim to improve safety and efficacy.
  • The debate between crystalloids and colloids, including HES, continues in clinical practice.

Purpose:

  • To review current knowledge on recent hydroxyethyl starch (HES) formulations.
  • To analyze the biophysics, pharmacology, toxicity, and clinical effects of HES.
  • To discuss the evolving role and limitations of HES in medical applications.

Summary:

  • Newer HES generations feature decreased molecular weight and altered molar substitution rates.
  • The primary goal of recent HES development is to reduce side effects, notably hemostasis and renal dysfunction.
  • The latest innovations include "balanced" HES solutions.

Impact:

  • Improved understanding of HES safety and efficacy in intensive care and perioperative settings.
  • Guidance on the appropriate use of modern HES products.
  • Informing future research and development of plasma volume expanders.